Life changing outcomes for Lung Transplant patients

Outcomes for lung transplant patients in Australia have improved vastly over the last three decades, with almost 70% of patients surviving for at least five years after their transplant. Although this shows tremendous progress and compares higher than international figures, survival rates are still significantly lower than for other organ transplantations. One of the major contributors to complications or death post-transplant is Chronic Lung Allograft Dysfunction, or CLAD.

With around 50% of patients developing CLAD within five years of transplant, research into early detection of the condition is crucial to improving the situation.

We are deeply grateful to The Alexandra and Lloyd Martin Family Foundation, whose support has allowed us to establish the Carina Martin Lung Transplant Research Fellowship, which continues advancing the work of our Lung Transplant Clinical Trials Unit and their potentially lifesaving, early detection rejection work.

Earlier this year, Dr Eisa Tahmasbpour (pictured above) took up the Fellowship under the continuing guidance of A/Director of Lung Transplantation at St Vincent’s, Dr David Darley. A centrepiece of their work is examining the role of eosinophilia, a type of immune cell, as a risk factor for cellular rejection. Their findings were presented at the International Society for Heart and Lung Transplant 43rd Annual Meeting in USA this year and will be published in the prestigious Journal of Heart and Lung Transplantation.

Transplant prehabilitation, lung function assessment tools and the ability to synthesise vast amounts of patient research data are also instrumental to a successful lung transplant program. The support of Geoff Cox and the Bluesand Foundation ensures our Lung Transplant Services and Clinical Trials Unit can continue this vital work and we thank them for their on-going commitment to St Vincent’s.

Help us breathe life into lung research.

The Foundation is also seeking support to cover the costs of Research Fellowships, Clinical Trials Coordinators and Research Assistants. Gifts can also help maintain the Lung Biobank and the Bronchoalveolar Lavage Blood Biobank; and support the latest diagnostic and predictive tools, novel lung function testing technologies and home monitoring technologies for lung patients.

To support these life changing lung research and treatment programs, click here or contact Susan Williams, Executive Director of Philanthropy of Planned Giving at susan.williams2@svha.org.au or 1800 800 595